HS
Insider
Harold H. Shlevin
DirectorHarold H. Shlevin (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $1.0M of GALT (171,790 sh across 7 lots, as filed), executed Dec 8 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Jun 29
Filed Jun 30
Median ADV $2.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
GALTRecent filings
GALTSALE
Galectin Therapeutics Inc.
View filing →
$112K22,268 sh × $5.04
Exec Jun 29
Filed Jun 30 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. View filing → $139K
19,793 sh × $7.04
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. View filing → $124K
19,793 sh × $6.27
Exec Dec 12 2025
Filed Dec 16 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. View filing → $1.0M
171,790 sh across 7 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET